Tirzepatide

Investigational GIP / GLP-1 Receptor Agonist

Overview

Tirzepatide is a synthetic peptide studied for dual activity at glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.

Current research examines receptor signaling, glucose homeostasis, metabolic pathways, energy regulation, appetite-related signaling, and associated physiological mechanisms.

Research Focus

  • GIP and GLP-1 receptor signaling

  • Glucose homeostasis and metabolic pathways

  • Appetite and satiety signaling

  • Energy-balance mechanisms

  • Metabolic and body-composition research

Product Specifications

Form: Lyophilized peptide

In-Stock Strengths: 10 mg, 20 mg

Special-Order Strengths: 5 mg, 15 mg, 30 mg, 40 mg, 50 mg, 60 mg, 80 mg, 100 mg, 120 mg

Special Orders

Additional strengths may be available by special order. Availability, pricing, and lead times are subject to confirmation.

Storage

Store refrigerated at 2–8°C, unless otherwise specified.

Research Use Only

For laboratory and research applications only. Not intended for human or veterinary use, consumption, diagnosis, treatment, or clinical application.

Toronto-Based • Expanding Canada-Wide
Serving Vancouver & Beyond

© 2026 IZA Biosciences. All rights reserved.

For Research Use Only. Products offered by IZA Biosciences are intended exclusively for laboratory and research purposes. They are not intended for human or veterinary use, consumption, diagnosis, treatment, cure, or prevention of any disease. Purchasers are responsible for ensuring that all products are handled and used in accordance with applicable laws, regulations, and institutional requirements.